{"id":93799,"date":"2023-12-19T13:39:40","date_gmt":"2023-12-19T08:09:40","guid":{"rendered":"http:\/\/finservwealth.com\/jb-pharma-inks-rs-964-cr-licence-deal-with-novartis-for-ophthalmology-brands\/"},"modified":"2023-12-19T13:39:40","modified_gmt":"2023-12-19T08:09:40","slug":"jb-pharma-inks-rs-964-cr-licence-deal-with-novartis-for-ophthalmology-brands","status":"publish","type":"post","link":"https:\/\/finservwealth.com\/hi\/jb-pharma-inks-rs-964-cr-licence-deal-with-novartis-for-ophthalmology-brands\/","title":{"rendered":"JB Pharma inks Rs 964-cr licence deal with Novartis for ophthalmology brands"},"content":{"rendered":"<p> As per IQVIA, MAT September, 2023 data, sales for these brands was at Rs 207.8 Crores.<\/p><div id=\"finse-3253297852\" class=\"finse-content finse-entity-placement\"><script async src=\"\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-9118214110898834\" crossorigin=\"anonymous\"><\/script><ins class=\"adsbygoogle\" style=\"display:block;\" data-ad-client=\"ca-pub-9118214110898834\" \ndata-ad-slot=\"\" \ndata-ad-format=\"auto\"><\/ins>\n<script> \n(adsbygoogle = window.adsbygoogle || []).push({}); \n<\/script>\n<\/div>\n<p><a href=\"https:\/\/www.moneycontrol.com\/news\/business\/jb-pharma-inks-rs-964-cr-licence-dealnovartis-for-ophthalmology-brands_17375001.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a><\/p>\n<p>\u200b\u00a0As per IQVIA, MAT September, 2023 data, sales for these brands was at Rs 207.8 Crores. As per IQVIA, MAT September, 2023 data, sales for these brands was at Rs 207.8 Crores.\u00a0\u00a0Moneycontrol Latest News\u00a0<a href=\"https:\/\/www.moneycontrol.com\/news\/business\/jb-pharma-inks-rs-964-cr-licence-dealnovartis-for-ophthalmology-brands_17375001.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a>\u00a0\u00a0<\/p>","protected":false},"excerpt":{"rendered":"<p><!-- wp:html --><\/p>\n<p> As per IQVIA, MAT September, 2023 data, sales for these brands was at Rs 207.8 Crores.<\/p>\n<p><a href=\"https:\/\/www.moneycontrol.com\/news\/business\/jb-pharma-inks-rs-964-cr-licence-dealnovartis-for-ophthalmology-brands_17375001.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a><\/p>\n<p>\u200b\u00a0As per IQVIA, MAT September, 2023 data, sales for these brands was at Rs 207.8 Crores. As per IQVIA, MAT September, 2023 data, sales for these brands was at Rs 207.8 Crores.\u00a0\u00a0Moneycontrol Latest News\u00a0<a href=\"https:\/\/www.moneycontrol.com\/news\/business\/jb-pharma-inks-rs-964-cr-licence-dealnovartis-for-ophthalmology-brands_17375001.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a>\u00a0\u00a0<\/p>\n<p><!-- \/wp:html --> As per IQVIA, MAT September, 2023 data, sales for these brands was at Rs 207.8 Crores.<\/p>","protected":false},"author":0,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"content-type":"","_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"neve_meta_sidebar":"","neve_meta_container":"","neve_meta_enable_content_width":"","neve_meta_content_width":0,"neve_meta_title_alignment":"","neve_meta_author_avatar":"","neve_post_elements_order":"","neve_meta_disable_header":"","neve_meta_disable_footer":"","neve_meta_disable_title":"","_themeisle_gutenberg_block_has_review":false,"footnotes":""},"categories":[70],"tags":[],"class_list":["post-93799","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-latest-news"],"jetpack_featured_media_url":"https:\/\/www.moneycontrol.com\/news_image_files\/2022\/200x200\/J\/JB-CHEM_200.jpg","_links":{"self":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/posts\/93799","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/comments?post=93799"}],"version-history":[{"count":0,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/posts\/93799\/revisions"}],"wp:attachment":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/media?parent=93799"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/categories?post=93799"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/tags?post=93799"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}